SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Alzheimer's Research and Therapy

Volumn 2, Issue 3, 2010, Pages

Con: Can biomarkers be gold standards in Alzheimer's disease?

(1) Rockwood, Kenneth a,b

a Capital District Health Authority (Canada)

b DALHOUSIE UNIVERSITY (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; DEMENTIA; GOLD STANDARD; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 77954159694 PISSN: None EISSN: 17589193 Source Type: Journal
DOI: 10.1186/alzrt40 Document Type: Short Survey

Times cited : (10)

References (7)

1
- 0035100888
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
- DOI 10.1067/mcp.2001.113989
- Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Biomarkers Definitions Working Group, Clin Pharmacol Ther 2001 69 89 95 10.1067/mcp.2001.113989 (Pubitemid 32225406)
- (2001) Clinical Pharmacology and Therapeutics , vol.69 , Issue.3 , pp. 89-95
- Atkinson Jr., A.J.¹ Colburn, W.A.² DeGruttola, V.G.³ DeMets, D.L.⁴ Downing, G.J.⁵ Hoth, D.F.⁶ Oates, J.A.⁷ Peck, C.C.⁸ Schooley, R.T.⁹ Spilker, B.A.¹⁰ Woodcock, J.¹¹ Zeger, S.L.¹²

2
- 33645021454
- 'Precision' and 'accuracy': Two terms that are neither
- 10.1016/j.jclinepi.2005.09.005. 16549250
- 'Precision' and 'accuracy': two terms that are neither. DL Streiner GR Norman, J Clin Epidemiol 2006 59 327 330 10.1016/j.jclinepi.2005.09.005 16549250
- (2006) J Clin Epidemiol , vol.59 , pp. 327-330
- Streiner, D.L.¹ Norman, G.R.²

3
- 0021482793
- Metachromatic leukodystrophy: Clincial and enzymatic parameters
- 10.1055/s-2008-1052373. 6152812
- Metachromatic leukodystrophy: clincial and enzymatic parameters. GM McKhann, Neuropediatrics 1984 15 Suppl 4 10 10.1055/s-2008-1052373 6152812
- (1984) Neuropediatrics , vol.15 , Issue.SUPPL. , pp. 4-10
- McKhann, G.M.¹

4
- 0031054674
- Brain infraction and the clinical expression of Alzheimer disease. The Nun Study
- 10.1001/jama.277.10.813. 9052711
- Brain infraction and the clinical expression of Alzheimer disease. The Nun Study. DA Snowdon LH Greiner JA Mortimer KP Riley PA Greiner WR Markesbery, JAMA 1997 277 813 817 10.1001/jama.277.10.813 9052711
- (1997) JAMA , vol.277 , pp. 813-817
- Snowdon, D.A.¹ Greiner, L.H.² Mortimer, J.A.³ Riley, K.P.⁴ Greiner, P.A.⁵ Markesbery, W.R.⁶

5
- 0035915621
- Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales
- Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study 10.1016/S0140-6736(00)03589-3. 11213093
- Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study, Lancet 2001 357 169 175 10.1016/S0140-6736(00)03589-3 11213093
- (2001) Lancet , vol.357 , pp. 169-175

6
- 29244459969
- The dynamics of international monetary systems: International and domestic factors in the rise, reign, and demise of the classical gold standard
- New York: Routledge Eichengreen B, Flandreau M 2
- The dynamics of international monetary systems: international and domestic factors in the rise, reign, and demise of the classical gold standard. JA Frieden, The Gold Standard in Theory and History New York: Routledge, Eichengreen B, Flandreau M, 2 1997 207 229
- (1997) The Gold Standard in Theory and History , pp. 207-229
- Frieden, J.A.¹

7
- 23244451582
- Biomarkers and surrogate markers: An FDA perspective
- 10.1602/neurorx.1.2.189. 15717019
- Biomarkers and surrogate markers: an FDA perspective. R Katz, NeuroRx 2004 1 189 195 10.1602/neurorx.1.2.189 15717019
- (2004) NeuroRx , vol.1 , pp. 189-195
- Katz, R.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.